(NASDAQ: PDSB) Pds Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.38%.
Pds Biotechnology's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast PDSB's revenue for 2028 to be $173,698,000, with the lowest PDSB revenue forecast at $173,698,000, and the highest PDSB revenue forecast at $173,698,000. On average, 1 Wall Street analysts forecast PDSB's revenue for 2029 to be $4,879,542,500, with the lowest PDSB revenue forecast at $4,879,542,500, and the highest PDSB revenue forecast at $4,879,542,500.
In 2030, PDSB is forecast to generate $10,331,968,430 in revenue, with the lowest revenue forecast at $10,331,968,430 and the highest revenue forecast at $10,331,968,430.